(window.webpackJsonp=window.webpackJsonp||[]).push([[23],{460:function(e,t,n){e.exports=n.p+"assets/img/DiseaseProgressionModel.c41dc1be.png"},496:function(e,t,n){"use strict";n.r(t);var i=n(69),a=Object(i.a)({},(function(){var e=this,t=e._self._c;return t("ContentSlotsDistributor",{attrs:{"slot-key":e.$parent.slotKey}},[t("h1",{attrs:{id:"episim-simulation"}},[t("a",{staticClass:"header-anchor",attrs:{href:"#episim-simulation"}},[e._v("#")]),e._v(" EpiSim - Simulation")]),e._v(" "),t("p",[e._v("So far, the scenario preparation process has been described; the\nepisim-config data structure, the various inputs, and the restriction\npolicies have been detailed. Now, it is time for the simulation to\nbegin. At the beginning of the simulation, a random set of individuals\nis infected. The class "),t("code",[e._v("EpisimRunner")]),e._v(" iterates through all the days\n(iterations) in the simulation. As previously mentioned, in the VSP\ncase, one simulated week involves replaying the weekday events five\ntimes, followed by the Saturday events and, finally, the Sunday events.")]),e._v(" "),t("p",[e._v("At the beginning of each day, there is a certain initialization phase:\ne.g. vaccinations and tests are administered to portions of the\npopulation. This is also where the disease progression model changes the\ndisease states of individuals (see "),t("em",[t("a",{attrs:{href:"#disease-progression-model"}},[e._v("Disease Progression Model")])]),e._v("). Based on transition probabilities, some\ninfectious individuals start, for example, to show symptoms or some\nseriously sick individuals recover.")]),e._v(" "),t("p",[e._v("At the beginning of a day, the "),t("code",[e._v("DefaultParticipationModel")]),e._v(" ascertains\nwhich activities should be skipped. Since the events file corresponds to\npre-coronavirus activity trajectories, a certain portion of planned\ndaily activities should be removed due to pandemic-induced mobility\nreductions. For each event in the day's events file, the applicable\n"),t("code",[e._v("remainingFraction")]),e._v(" is extracted from the "),t("code",[e._v("Restriction")]),e._v(" for the activity\ntype and date in question. A random number between 0.0 and 1.0 is then\ngenerated; if it lies above the "),t("code",[e._v("remainingFraction")]),e._v(", then the activity\nwill not occur on this day. Thus, for a "),t("code",[e._v("remainingFraction")]),e._v(" of 66% at\nwork, approximately one-third of all work activities for that day will\nnot occur. If an activity is skipped, then the associated public transit\ntravel to (and from) that activity will also not be realized.")]),e._v(" "),t("p",[e._v("Each day is simulated as follows: the corresponding events file is\nreplayed minute-by-minute, by processing the events chronologically.\nEpiSim predicts\ndaily infection dynamics using three interlocking sub-models: the\ncontact model identifies situations where agents meet; given an agent is\ninfectious, the infection model predicts whether\nSARS-CoV-2 is transmitted\nto a susceptible agent; if an agent is infected, the disease progression\nmodel determines the course and severity of the disease\n("),t("a",{attrs:{href:"https://doi.org/10.48550/arXiv.2011.11453",target:"_blank",rel:"noopener noreferrer"}},[e._v("Müller 2020"),t("OutboundLink")],1),e._v("). Following, these three core models will be\nintroduced, as well as two optional submodels: the vaccination and\nantibody models.")]),e._v(" "),t("h2",{attrs:{id:"contact-model"}},[t("a",{staticClass:"header-anchor",attrs:{href:"#contact-model"}},[e._v("#")]),e._v(" Contact Model")]),e._v(" "),t("p",[e._v("The "),t("code",[e._v("DefaultContactModel")]),e._v(" starts the day with a set of empty containers,\ncorresponding to all the enclosed spaces where agents can meet (activity\nfacilities and public transit vehicles). The "),t("code",[e._v("ReplayHandler")]),e._v(" class then\nreplays all the events that occur in a day in chronological order.")]),e._v(" "),t("p",[e._v("If an activity occurs (as specified by the "),t("code",[e._v("DefaultParticipationModel")]),e._v("),\nthe "),t("code",[e._v("DefaultContactModel")]),e._v(" will then add the agent in question to the\ncorresponding container. When the events file specifies that an agent\nends an activity, the "),t("code",[e._v("DefaultContactModel")]),e._v(" checks whether at least one\nperson in the container is susceptible and one is infectious. If so,\nthis agent-pair is passed along to the "),t("code",[e._v("InfectionEventHandler")]),e._v(", which\nwill check whether an infection actually occurs. This same process also\noccurs when an agents enters or leaves a public transit vehicle\n("),t("a",{attrs:{href:"https://doi.org/10.48550/arXiv.2011.11453",target:"_blank",rel:"noopener noreferrer"}},[e._v("Müller 2020"),t("OutboundLink")],1),e._v(").")]),e._v(" "),t("h2",{attrs:{id:"infection-model"}},[t("a",{staticClass:"header-anchor",attrs:{href:"#infection-model"}},[e._v("#")]),e._v(" Infection Model")]),e._v(" "),t("p",[e._v("If the contact model renders that a contagious person met with a\nsusceptible person, then the infection model calculates the probability\nthat an infection occurs. EpiSim uses a mechanical infection model (\n"),t("a",{attrs:{href:"https://doi.org/10.1186/1742-4682-6-25",target:"_blank",rel:"noopener noreferrer"}},[e._v("Smieszek 2009"),t("OutboundLink")],1),e._v(", "),t("a",{attrs:{href:"https://doi.org/10.1186/1471-2334-11-115",target:"_blank",rel:"noopener noreferrer"}},[e._v("Smieszek 2011"),t("OutboundLink")],1),e._v(")"),t("sup",{staticClass:"footnote-ref"},[t("a",{attrs:{href:"#fn1",id:"fnref1"}},[e._v("[1]")])]),e._v(". The\nfollowing is a simplified model version, which is useful for explanatory\npurposes:")]),e._v(" "),t("p",[t("em",[e._v("p(infect|contact) ≈ Θ × sh × ci × in × τ.")])]),e._v(" "),t("p",[e._v('Here, the "shedding rate", '),t("em",[e._v("sh")]),e._v(', is the viral load that the infected\nperson produces through exhalation; this is dependent on what stage of\nthe disease the person is in and whether they are wearing a mask.\nConversely, the "intake rate", '),t("em",[e._v("in")]),e._v(', is how much viral load a\nsusceptible agent breathes in, which is also dependent on mask-usage.\nAge-dependent susceptibility and\ninfectivity, which were defined in the episim-config,\nalso play a role in the shedding and intake rates. The "contact\nintensity", '),t("em",[e._v("ci")]),e._v(", describes the aerodynamic characteristics of the\nroom, which impact the viral load, including size of the room and how\nmuch air exchange takes place (i.e. through the opening of windows).\nFinally, the duration of contact "),t("em",[e._v("τ")]),e._v(" is an important factor, which\ncan be gleaned from the activity trajectories. The calibration factor,\n"),t("em",[e._v("Θ")]),e._v(", is determined through model calibration; this also absorbs all\nunits of the individual factors. All of this together predicts whether\nsusceptible individuals become infected with SARS-CoV-2 during an\ninteraction with an infectious person. For additional details, see\n("),t("a",{attrs:{href:"https://doi.org/10.48550/arXiv.2011.11453",target:"_blank",rel:"noopener noreferrer"}},[e._v("Müller 2020"),t("OutboundLink")],1),e._v(").")]),e._v(" "),t("h2",{attrs:{id:"disease-progression-model"}},[t("a",{staticClass:"header-anchor",attrs:{href:"#disease-progression-model"}},[e._v("#")]),e._v(" Disease Progression Model")]),e._v(" "),t("p",[e._v("After an agent is infected with SARS-CoV-2, the disease progression\nmodel is used to determine if COVID-19 develops and if (and when) certain\ndisease stages occur. When the infection model reports that a\n"),t("code",[e._v("susceptible")]),e._v(" person is infected, the agent is initially assigned the\nstate of "),t("code",[e._v("infectedButNotContagious")]),e._v(". At the beginning of each iteration\n(simulated day), there will be a certain chance for the infection state\nof the agent to change. The worst\npossible progression would be as follows:\n"),t("code",[e._v("infectedButNotContagious")]),e._v(" → "),t("code",[e._v("infectious")]),e._v("\n→ "),t("code",[e._v("showingSymptoms")]),e._v(" → "),t("code",[e._v("seriouslySick")]),e._v(" → "),t("code",[e._v("critical")]),e._v(" → "),t("code",[e._v("seriouslySick")]),e._v(" → "),t("code",[e._v("recovered")]),t("sup",{staticClass:"footnote-ref"},[t("a",{attrs:{href:"#fn2",id:"fnref2"}},[e._v("[2]")])]),e._v(". However, starting with the\n"),t("code",[e._v("infectious")]),e._v(" state, there is always a chance of becoming "),t("code",[e._v("recovered")]),e._v(".")]),e._v(" "),t("p",[t("img",{attrs:{src:n(460),alt:"Example Image"}}),e._v(" "),t("em",[e._v("Visualization of progression model. See also "),t("a",{attrs:{href:"https://doi.org/10.48550/arXiv.2011.11453",target:"_blank",rel:"noopener noreferrer"}},[e._v("Müller 2020"),t("OutboundLink")],1)]),e._v(".")]),e._v(" "),t("p",[e._v("The progression model uses age-dependent transition probabilities to\ndetermine whether the agent moves to a more dire state or to the\n"),t("code",[e._v("recovered")]),e._v(" state. The progression model also sets the duration of each\nstate based on medians and standard deviations found in the literature.\nThe agent can only infect other agents in the infectious state or within\nthe first few days of the showing symptoms state; in later states, it is\nassumed that the agent is either isolating at home or in the hospital.\nReaders who would like more information on the sources of the transition\nprobabilities are encouraged to read Section 2.3 of\n("),t("a",{attrs:{href:"https://doi.org/10.48550/arXiv.2011.11453",target:"_blank",rel:"noopener noreferrer"}},[e._v("Müller 2020"),t("OutboundLink")],1),e._v(").")]),e._v(" "),t("h2",{attrs:{id:"vaccination-model"}},[t("a",{staticClass:"header-anchor",attrs:{href:"#vaccination-model"}},[e._v("#")]),e._v(" Vaccination Model")]),e._v(" "),t("p",[e._v("Historical vaccinations, which are administered to a portion of the\npopulation at the beginning of each day, are implemented in\n"),t("code",[e._v("VaccinationFromData")]),e._v(". To accurately represent the vaccination quotas\nper age group and manufacturer shares in EpiSim, the model adheres to\nthe official German vaccination quotas and manufacturer shares provided\nby "),t("a",{attrs:{href:"https://doi.org10.5281/zenodo.12697471",target:"_blank",rel:"noopener noreferrer"}},[e._v("rki"),t("OutboundLink")],1),e._v("; thus ensuring alignment with the actual\ndistribution within the German population. RKI provides the number of vaccinations per\ndate for four age groups (5-11, 12-7, 18-59 and 60+ years old) on the\ncounty level and the number of vaccinations per manufacturer (i.e.\nComirnaty, Spikevax, Vaxzevria) on the federal state level. In EpiSim,\nagents are divided into the same age groups. However, only agents who\nare a) "),t("code",[e._v("susceptible")]),e._v(", b) have not been vaccinated in the previous 90\ndays, and c) have not been infected during the previous 90 days are\neligible for vaccination. For the booster vaccine, agents must\nadditionally have already been vaccinated to be considered eligible, and\nfor the second booster, agents must have already been boostered to be\nconsidered eligible. Per age group and per manufacturer, the available\ndoses per manufacturer are then randomly given to the eligible agents.\nFor each agent, the latest vaccination date, the number of vaccinations\nas well as the vaccination type they received are saved"),t("sup",{staticClass:"footnote-ref"},[t("a",{attrs:{href:"#fn3",id:"fnref3"}},[e._v("[3]")])]),e._v(".")]),e._v(" "),t("h2",{attrs:{id:"antibody-model"}},[t("a",{staticClass:"header-anchor",attrs:{href:"#antibody-model"}},[e._v("#")]),e._v(" Antibody Model")]),e._v(" "),t("p",[e._v("Antibody levels of individual agents are implemented in\n"),t("code",[e._v("DefaultAntibodyModel")]),e._v(". After the first immunization event (either\nvaccination or infection), an agent's strain-specific antibody levels\nare set. A relative antibody level of 0 translates to no protection,\nwhile a relative antibody level of 1 translates to 50% protection\nagainst infection. However, these antibody levels are dynamic and may,\ndue to waning, decrease over time. An additional immunization event,\neither via infection or via vaccination, is necessary to boost the\nagent's antibody levels again. For a detailed discussion of\nEpiSim's\nantibody model see "),t("a",{attrs:{href:"http://dx.doi.org/10.1016/j.isci.2023.107554",target:"_blank",rel:"noopener noreferrer"}},[e._v("Müller 2023"),t("OutboundLink")],1),e._v(".")]),e._v(" "),t("hr",{staticClass:"footnotes-sep"}),e._v(" "),t("section",{staticClass:"footnotes"},[t("ol",{staticClass:"footnotes-list"},[t("li",{staticClass:"footnote-item",attrs:{id:"fn1"}},[t("p",[e._v('The equation used in [episim]{acronym-label="episim"\nacronym-form="singular+short"} to calculate the probability of\ninfection along with a detailed explanation can be found in\n('),t("a",{attrs:{href:"https://doi.org/10.48550/arXiv.2011.11453",target:"_blank",rel:"noopener noreferrer"}},[e._v("Müller 2020"),t("OutboundLink")],1),e._v("). "),t("a",{staticClass:"footnote-backref",attrs:{href:"#fnref1"}},[e._v("↩︎")])])]),e._v(" "),t("li",{staticClass:"footnote-item",attrs:{id:"fn2"}},[t("p",[e._v("There is no death in Episim. "),t("a",{staticClass:"footnote-backref",attrs:{href:"#fnref2"}},[e._v("↩︎")])])]),e._v(" "),t("li",{staticClass:"footnote-item",attrs:{id:"fn3"}},[t("p",[e._v("If current vaccination data is unavailable or if future\ndevelopers/users decide not to follow the vaccination quotas\nprovided by RKI, alternative vaccination strategies may be\nimplemented. "),t("a",{staticClass:"footnote-backref",attrs:{href:"#fnref3"}},[e._v("↩︎")])])])])])])}),[],!1,null,null,null);t.default=a.exports}}]);